The C-terminal region of BRCA2 apparently necessary for PAF1 recruitment is often deleted in truncating mutations associated with breast and ovarian cancer (Rebbeck et al., 2015), suggesting its functional significance in tumor suppression. Here, BRCA2 is linked to ovarian cancer.